Journal
CELL
Volume 132, Issue 3, Pages 397-409Publisher
CELL PRESS
DOI: 10.1016/j.cell.2008.01.016
Keywords
-
Categories
Funding
- BBSRC [BB/E021301/1, BB/E02145X/1] Funding Source: UKRI
- MRC [MC_U120074259, MC_U130115834] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [BB/E021301/1, BB/E02145X/1] Funding Source: researchfish
- Medical Research Council [MC_U120074259] Funding Source: researchfish
- Biotechnology and Biological Sciences Research Council [BB/E02145X/1, BB/E021301/1] Funding Source: Medline
- Medical Research Council [MC_U130115834, MC_U120074259] Funding Source: Medline
Ask authors/readers for more resources
Adenoviruses are used extensively as gene transfer agents, both experimentally and clinically. However, targeting of liver cells by adenoviruses compromises their potential efficacy. In cell culture, the adenovirus serotype 5 fiber protein engages the coxsackievirus and adenovirus receptor (CAR) to bind cells. Paradoxically, following intravascular delivery, CAR is not used for liver transduction, implicating alternate pathways. Recently, we demonstrated that coagulation factor (F)X directly binds adenovirus leading to liver infection. Here, we show that FX binds to the Ad5 hexon, not fiber, via an interaction between the FX Gla domain and hypervariable regions of the hexon surface. Binding occurs in multiple human adenovirus serotypes. Liver infection by the FX-Ad5 complex is mediated through a heparin-binding exosite in the FX serine protease domain. This study reveals an unanticipated function for hexon in mediating liver gene transfer in vivo.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available